A study of pharmacogenomics for therapeutic and prognostic guidance towards hepatitis C virus (HCV) for patients co-infected with HIV
The cost effectiveness of using novel HCV treatment option, telaprevir and boceprevir, should depend on patients’ respond to conventional PEG-INFα and ribavirin therapy. The study of pharmacogenomics, interleukin-28B (IL-28B) polymorphisms, accompanied with the information of HCV genotypes are sugge...
| Main Authors: | , |
|---|---|
| Language: | English |
| Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10722/193555 |